Table 3.
Hospitalization in COVID-19 confirmed institutionalized patients over 64 years of age who died.
| Mortality at 90 days (N = 1,458) | No hospitalization (N = 523) | Hospitalization (N = 935) | p | |
|---|---|---|---|---|
| Sex | 0.001* | |||
| Male | 587 (40.26%) | 181 (34.61%) | 406 (43.42%) | |
| Female | 871 (59.74%) | 342 (65.39%) | 529 (56.58%) | |
| Age | 0.072 | |||
| 65–79 | 140 (9.60%) | 40 (7.65%) | 100 (10.70%) | |
| ≥80 | 1,318 (90.40%) | 483 (92.35%) | 835 (89.30%) | |
| Socioeconomic level | 0.247 | |||
| Mutualist | 30 (2.06%) | 11 (2.10%) | 19 (2.03%) | |
| Pensioner <18,000€/year | 1,171 (80.32%) | 435 (83.17%) | 736 (78.72%) | |
| Pensioner ≥ 18,000€/year | 196 (13.44%) | 57 (10.90%) | 139 (14.87%) | |
| Free medicines | 56 (3.84%) | 18 (3.44%) | 38 (4.06%) | |
| Other | 5 (0.34%) | 2 (0.38%) | 3 (0.32%) | |
| Number of diseases (a) | 6.00 [5.00;8.00] | 6.00 [4.00;8.00] | 6.00 [5.00;8.00] | 0.022 * |
| Complexity (a) | 3.00 [2.00;4.00] | 3.00 [2.00;4.00] | 3.00 [2.00;4.00] | 0.774 |
| Diagnosis | ||||
| Diabetes mellitus | 395 (27.45%) | 116 (22.66%) | 279 (30.10%) | 0.003* |
| Obesity | 162 (11.26%) | 46 (8.98%) | 116 (12.51%) | 0.052 |
| Hypertension | 1,021 (70.95%) | 357 (69.73%) | 664 (71.63%) | 0.484 |
| Stroke | 227 (15.77%) | 76 (14.84%) | 151 (16.29%) | 0.519 |
| Ischemic heart disease | 167 (11.61%) | 50 (9.77%) | 117 (12.62%) | 0.125 |
| Heart failure | 219 (15.22%) | 60 (11.72%) | 159 (17.15%) | 0.008* |
| COPD | 172 (11.95%) | 57 (11.13%) | 115 (12.41%) | 0.530 |
| Chronic kidney disease | 461 (32.04%) | 157 (30.66%) | 304 (32.79%) | 0.441 |
| Depression | 402 (27.94%) | 142 (27.73%) | 260 (28.05%) | 0.948 |
| Dementia | 526 (36.55%) | 224 (43.75%) | 302 (32.58%) | <0.001* |
Sociodemographic and clinical characteristics.
N, number; p, statistical significance; a, results expressed as median and interquartile range; COPD, chronic obstructive pulmonary disease.
*Statistically significant results.